Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Transcriptome profiling of adipose tissue reveals depot-specific metabolic alterations among colorectal cancer patients.

Haffa M, Lin T, Holowatyj AN, Kratz M, Toth R, Benner A, Gigic B, Habermann N, Schrotz-King P, Böhm J, Brenner H, Schneider M, Ulrich A, Herpel E, Schirmacher P, Straub BK, Nattenmüller J, Kauczor HU, Ball CR, Ulrich CM, Glimm H, Scherer D.

J Clin Endocrinol Metab. 2019 Jun 21. pii: jc.2019-00461. doi: 10.1210/jc.2019-00461. [Epub ahead of print]

PMID:
31225875
2.

Systematic Generation of Patient-Derived Tumor Models in Pancreatic Cancer.

Ehrenberg KR, Gao J, Oppel F, Frank S, Kang N, Dieter SM, Herbst F, Möhrmann L, Dubash TD, Schulz ER, Strakerjahn H, Giessler KM, Weber S, Oberlack A, Rief EM, Strobel O, Bergmann F, Lasitschka F, Weitz J, Glimm H, Ball CR.

Cells. 2019 Feb 10;8(2). pii: E142. doi: 10.3390/cells8020142.

3.

A Wolter imager on the Z machine to diagnose warm x-ray sources.

Fein JR, Ampleford DJ, Vogel JK, Kozioziemski B, Walton CC, Wu M, Ball CR, Ames A, Ayers J, Bell P, Bourdon CJ, Bradley D, Bruni R, Dunham GS, Gard PD, Johnson D, Kilaru K, Kirtley C, Lake PW, Maurer A, Nielsen-Weber L, Pickworth LA, Pivovaroff MJ, Ramsey B, Roberts OJ, Rochau GA, Romaine S, Sullivan M.

Rev Sci Instrum. 2018 Oct;89(10):10G115. doi: 10.1063/1.5038347.

PMID:
30399891
4.

An x-ray optic calibration facility for high energy density diagnostics.

Kozioziemski BJ, Ayers J, Bell P, Bradley DK, Descalle MA, Hau-Riege S, McCarville TJ, Pardini T, Pickworth LA, Vogel JK, Stone J, Robinson J, Ampleford DJ, Ball CR, Bourdon CJ, Fein JR, Wu M, Ames A, Bruni R, Romaine S.

Rev Sci Instrum. 2018 Oct;89(10):10G112. doi: 10.1063/1.5038742.

PMID:
30399878
5.

Design and raytrace simulations of a multilayer-coated Wolter x-ray optic for the Z machine at Sandia National Laboratories.

Vogel JK, Pivovaroff MJ, Kozioziemski B, Walton CC, Ayers J, Bell P, Bradley D, Descalle MA, Hau-Riege S, Pickworth LA, Ampleford DJ, Ball CR, Bourdon CJ, Fein JR, Gard PD, Maurer A, Wu M, Ames A, Bruni R, Romaine S, Kilaru K, Roberts OJ, Ramsey B.

Rev Sci Instrum. 2018 Oct;89(10):10G113. doi: 10.1063/1.5038811.

PMID:
30399826
6.

One dimensional imager of neutrons on the Z machine.

Ampleford DJ, Ruiz CL, Fittinghoff DN, Vaughan JD, Hahn K, Lahmann B, Gatu-Johnson M, Frenje J, Petrasso R, Ball CR, Maurer AJ, Knapp PF, Harvey-Thompson AJ, Fisher J, Alberto P, Torres JA, Cooper G, Jones B, Rochau GA, May MJ.

Rev Sci Instrum. 2018 Oct;89(10):10I132. doi: 10.1063/1.5038118.

PMID:
30399820
7.

Mapping Active Gene-Regulatory Regions in Human Repopulating Long-Term HSCs.

Wünsche P, Eckert ESP, Holland-Letz T, Paruzynski A, Hotz-Wagenblatt A, Fronza R, Rath T, Gil-Farina I, Schmidt M, von Kalle C, Klein C, Ball CR, Herbst F, Glimm H.

Cell Stem Cell. 2018 Jul 5;23(1):132-146.e9. doi: 10.1016/j.stem.2018.06.003.

8.

Cell-of-Origin DNA Methylation Signatures Are Maintained during Colorectal Carcinogenesis.

Bormann F, Rodríguez-Paredes M, Lasitschka F, Edelmann D, Musch T, Benner A, Bergman Y, Dieter SM, Ball CR, Glimm H, Linhart HG, Lyko F.

Cell Rep. 2018 Jun 12;23(11):3407-3418. doi: 10.1016/j.celrep.2018.05.045.

9.

NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer.

Heining C, Horak P, Uhrig S, Codo PL, Klink B, Hutter B, Fröhlich M, Bonekamp D, Richter D, Steiger K, Penzel R, Endris V, Ehrenberg KR, Frank S, Kleinheinz K, Toprak UH, Schlesner M, Mandal R, Schulz L, Lambertz H, Fetscher S, Bitzer M, Malek NP, Horger M, Giese NA, Strobel O, Hackert T, Springfeld C, Feuerbach L, Bergmann F, Schröck E, von Kalle C, Weichert W, Scholl C, Ball CR, Stenzinger A, Brors B, Fröhling S, Glimm H.

Cancer Discov. 2018 Sep;8(9):1087-1095. doi: 10.1158/2159-8290.CD-18-0036. Epub 2018 May 25.

PMID:
29802158
10.

Targeted BiTE Expression by an Oncolytic Vector Augments Therapeutic Efficacy Against Solid Tumors.

Speck T, Heidbuechel JPW, Veinalde R, Jaeger D, von Kalle C, Ball CR, Ungerechts G, Engeland CE.

Clin Cancer Res. 2018 May 1;24(9):2128-2137. doi: 10.1158/1078-0432.CCR-17-2651. Epub 2018 Feb 6.

11.

An ELISA method to estimate the mono ADP-ribosyltransferase activities: e.g in pertussis toxin and vaccines.

Asokanathan C, Tierney S, Ball CR, Buckle G, Day A, Tanley S, Bristow A, Markey K, Xing D, Yuen CT.

Anal Biochem. 2018 Jan 1;540-541:15-19. doi: 10.1016/j.ab.2017.10.025. Epub 2017 Nov 9.

PMID:
29108883
12.

Genetic subclone architecture of tumor clone-initiating cells in colorectal cancer.

Giessler KM, Kleinheinz K, Huebschmann D, Balasubramanian GP, Dubash TD, Dieter SM, Siegl C, Herbst F, Weber S, Hoffmann CM, Fronza R, Buchhalter I, Paramasivam N, Eils R, Schmidt M, von Kalle C, Schneider M, Ulrich A, Scholl C, Fröhling S, Weichert W, Brors B, Schlesner M, Ball CR, Glimm H.

J Exp Med. 2017 Jul 3;214(7):2073-2088. doi: 10.1084/jem.20162017. Epub 2017 Jun 1.

13.

Colorectal cancer-initiating cells caught in the act.

Dieter SM, Glimm H, Ball CR.

EMBO Mol Med. 2017 Jul;9(7):856-858. doi: 10.15252/emmm.201707858. No abstract available.

14.

Succession of transiently active tumor-initiating cell clones in human pancreatic cancer xenografts.

Ball CR, Oppel F, Ehrenberg KR, Dubash TD, Dieter SM, Hoffmann CM, Abel U, Herbst F, Koch M, Werner J, Bergmann F, Ishaque N, Schmidt M, von Kalle C, Scholl C, Fröhling S, Brors B, Weichert W, Weitz J, Glimm H.

EMBO Mol Med. 2017 Jul;9(7):918-932. doi: 10.15252/emmm.201607354.

15.

Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation.

Dieter SM, Giessler KM, Kriegsmann M, Dubash TD, Möhrmann L, Schulz ER, Siegl C, Weber S, Strakerjahn H, Oberlack A, Heger U, Gao J, Hartinger EM, Oppel F, Hoffmann CM, Ha N, Brors B, Lasitschka F, Ulrich A, Strobel O, Schmidt M, von Kalle C, Schneider M, Weichert W, Ehrenberg KR, Glimm H, Ball CR.

Int J Cancer. 2017 Mar 15;140(6):1356-1363. doi: 10.1002/ijc.30561.

16.

The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment.

Fan F, Bashari MH, Morelli E, Tonon G, Malvestiti S, Vallet S, Jarahian M, Seckinger A, Hose D, Bakiri L, Sun C, Hu Y, Ball CR, Glimm H, Sattler M, Goldschmidt H, Wagner EF, Tassone P, Jaeger D, Podar K.

Leukemia. 2017 Jul;31(7):1570-1581. doi: 10.1038/leu.2016.358. Epub 2016 Nov 28.

PMID:
27890927
17.

Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.

Weischenfeldt J, Dubash T, Drainas AP, Mardin BR, Chen Y, Stütz AM, Waszak SM, Bosco G, Halvorsen AR, Raeder B, Efthymiopoulos T, Erkek S, Siegl C, Brenner H, Brustugun OT, Dieter SM, Northcott PA, Petersen I, Pfister SM, Schneider M, Solberg SK, Thunissen E, Weichert W, Zichner T, Thomas R, Peifer M, Helland A, Ball CR, Jechlinger M, Sotillo R, Glimm H, Korbel JO.

Nat Genet. 2017 Jan;49(1):65-74. doi: 10.1038/ng.3722. Epub 2016 Nov 21.

18.

Phenotypic differentiation does not affect tumorigenicity of primary human colon cancer initiating cells.

Dubash TD, Hoffmann CM, Oppel F, Giessler KM, Weber S, Dieter SM, Hüllein J, Zenz T, Herbst F, Scholl C, Weichert W, Werft W, Benner A, Schmidt M, Schneider M, Glimm H, Ball CR.

Cancer Lett. 2016 Feb 28;371(2):326-33. doi: 10.1016/j.canlet.2015.11.037. Epub 2015 Dec 8.

PMID:
26679053
19.

The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency.

Hufton SE, Risley P, Ball CR, Major D, Engelhardt OG, Poole S.

PLoS One. 2014 Aug 1;9(8):e103294. doi: 10.1371/journal.pone.0103294. eCollection 2014.

20.

Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.

Braun CJ, Boztug K, Paruzynski A, Witzel M, Schwarzer A, Rothe M, Modlich U, Beier R, Göhring G, Steinemann D, Fronza R, Ball CR, Haemmerle R, Naundorf S, Kühlcke K, Rose M, Fraser C, Mathias L, Ferrari R, Abboud MR, Al-Herz W, Kondratenko I, Maródi L, Glimm H, Schlegelberger B, Schambach A, Albert MH, Schmidt M, von Kalle C, Klein C.

Sci Transl Med. 2014 Mar 12;6(227):227ra33. doi: 10.1126/scitranslmed.3007280.

21.

Wnt secretion is required to maintain high levels of Wnt activity in colon cancer cells.

Voloshanenko O, Erdmann G, Dubash TD, Augustin I, Metzig M, Moffa G, Hundsrucker C, Kerr G, Sandmann T, Anchang B, Demir K, Boehm C, Leible S, Ball CR, Glimm H, Spang R, Boutros M.

Nat Commun. 2013;4:2610. doi: 10.1038/ncomms3610.

22.

Transforming growth factor beta receptor 2 (TGFBR2) changes sialylation in the microsatellite unstable (MSI) Colorectal cancer cell line HCT116.

Lee J, Ballikaya S, Schönig K, Ball CR, Glimm H, Kopitz J, Gebert J.

PLoS One. 2013;8(2):e57074. doi: 10.1371/journal.pone.0057074. Epub 2013 Feb 27.

23.

Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus.

Bach P, Abel T, Hoffmann C, Gal Z, Braun G, Voelker I, Ball CR, Johnston IC, Lauer UM, Herold-Mende C, Mühlebach MD, Glimm H, Buchholz CJ.

Cancer Res. 2013 Jan 15;73(2):865-74. doi: 10.1158/0008-5472.CAN-12-2221. Epub 2013 Jan 4.

24.

A methodology for calibrating wavelength dependent spectral resolution for crystal spectrometers.

Loisel G, Bailey JE, Rochau GA, Dunham GS, Nielsen-Weber LB, Ball CR.

Rev Sci Instrum. 2012 Oct;83(10):10E133. doi: 10.1063/1.4740269.

PMID:
23126954
25.

Stable long-term blood formation by stem cells in murine steady-state hematopoiesis.

Zavidij O, Ball CR, Herbst F, Oppel F, Fessler S, Schmidt M, von Kalle C, Glimm H.

Stem Cells. 2012 Sep;30(9):1961-70. doi: 10.1002/stem.1151.

26.

Targeting of KRAS mutant tumors by HSP90 inhibitors involves degradation of STK33.

Azoitei N, Hoffmann CM, Ellegast JM, Ball CR, Obermayer K, Gößele U, Koch B, Faber K, Genze F, Schrader M, Kestler HA, Döhner H, Chiosis G, Glimm H, Fröhling S, Scholl C.

J Exp Med. 2012 Apr 9;209(4):697-711. doi: 10.1084/jem.20111910. Epub 2012 Mar 26.

27.

Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivo.

Herbst F, Ball CR, Tuorto F, Nowrouzi A, Wang W, Zavidij O, Dieter SM, Fessler S, van der Hoeven F, Kloz U, Lyko F, Schmidt M, von Kalle C, Glimm H.

Mol Ther. 2012 May;20(5):1014-21. doi: 10.1038/mt.2012.46. Epub 2012 Mar 20.

28.

You can count on this: barcoded hematopoietic stem cells.

Glimm H, Ball CR, von Kalle C.

Cell Stem Cell. 2011 Nov 4;9(5):390-2. doi: 10.1016/j.stem.2011.10.013.

29.

Distinct types of tumor-initiating cells form human colon cancer tumors and metastases.

Dieter SM, Ball CR, Hoffmann CM, Nowrouzi A, Herbst F, Zavidij O, Abel U, Arens A, Weichert W, Brand K, Koch M, Weitz J, Schmidt M, von Kalle C, Glimm H.

Cell Stem Cell. 2011 Oct 4;9(4):357-65. doi: 10.1016/j.stem.2011.08.010.

30.

10-year stability of clinical-grade serum-free γ-retroviral vector-containing medium.

Herbst F, Ball CR, Zavidij O, Fessler S, Schmidt M, Veelken H, von Kalle C, Glimm H.

Gene Ther. 2011 Feb;18(2):210-2. doi: 10.1038/gt.2010.126. Epub 2010 Nov 11.

PMID:
21068779
31.

Stem-cell gene therapy for the Wiskott-Aldrich syndrome.

Boztug K, Schmidt M, Schwarzer A, Banerjee PP, Díez IA, Dewey RA, Böhm M, Nowrouzi A, Ball CR, Glimm H, Naundorf S, Kühlcke K, Blasczyk R, Kondratenko I, Maródi L, Orange JS, von Kalle C, Klein C.

N Engl J Med. 2010 Nov 11;363(20):1918-27. doi: 10.1056/NEJMoa1003548.

32.

Hematopoietic activity of human short-term repopulating cells in mobilized peripheral blood cell transplants is restricted to the first 5 months after transplantation.

Zavidij O, Ball CR, Herbst F, Fessler S, Schmidt M, von Kalle C, Glimm H.

Blood. 2010 Jun 17;115(24):5023-5. doi: 10.1182/blood-2010-02-271528. Epub 2010 Apr 9.

33.

Comprehensive genomic access to vector integration in clinical gene therapy.

Gabriel R, Eckenberg R, Paruzynski A, Bartholomae CC, Nowrouzi A, Arens A, Howe SJ, Recchia A, Cattoglio C, Wang W, Faber K, Schwarzwaelder K, Kirsten R, Deichmann A, Ball CR, Balaggan KS, Yáñez-Muñoz RJ, Ali RR, Gaspar HB, Biasco L, Aiuti A, Cesana D, Montini E, Naldini L, Cohen-Haguenauer O, Mavilio F, Thrasher AJ, Glimm H, von Kalle C, Saurin W, Schmidt M.

Nat Med. 2009 Dec;15(12):1431-6. doi: 10.1038/nm.2057. Epub 2009 Nov 22.

PMID:
19966782
34.

The inherent differentiation program of short-term hematopoietic repopulating cells changes during human ontogeny.

Tacke M, Ball CR, Schmidt M, Klingenberg S, Maurer B, Fessler S, Eaves CJ, von Kalle C, Glimm H.

Stem Cells Dev. 2010 May;19(5):621-8. doi: 10.1089/scd.2009.0202.

PMID:
19788397
35.

Stable differentiation and clonality of murine long-term hematopoiesis after extended reduced-intensity selection for MGMT P140K transgene expression.

Ball CR, Pilz IH, Schmidt M, Fessler S, Williams DA, von Kalle C, Glimm H.

Blood. 2007 Sep 15;110(6):1779-87. Epub 2007 May 11.

36.

The Anatomy Department of the University of Mississippi Medical Center. A short, anecdotal history.

Ball CR.

J Miss State Med Assoc. 1998 Nov;39(11):393-405. No abstract available.

PMID:
9813963
37.

The Anatomy Department of the University of Mississippi Medical Center. A short, anecdotal history. I.

Ball CR.

J Miss State Med Assoc. 1998 Oct;39(10):345-64. No abstract available.

PMID:
9796179
38.

Insulin reversal of diabetes-induced inhibition of vascular contractility in the rat.

Pfaffman MA, Ball CR, Darby A, Hilman R.

Am J Physiol. 1982 Apr;242(4):H490-5.

PMID:
7039365
39.

Diet-induced atrial endothelial damage--a scanning electron-microscopic study.

Davenport WD Jr, Ball CR.

Atherosclerosis. 1981 Oct;40(2):145-52.

PMID:
7306255
41.
42.

Transplantable colon tumors as chemotherapy screening models.

Ball CR, Double JA.

Cancer. 1975 Dec;36(6 Suppl):2437-40.

PMID:
174794
43.

Chemotherapy of transplanted adenocarcinomas of the colon in mice.

Double JA, Ball CR.

Cancer Chemother Rep. 1975 Nov-Dec;59(6):1083-9.

PMID:
1222393
44.

Proceedings: The role of alkaline phosphatase in the release of p-hydroxy aniline mustard from its phosphate conjugate.

Workman P, Double JA, Ball CR.

Br J Cancer. 1975 Aug;32(2):246. No abstract available.

45.

Proceedings: Transplantable adenocarcinomata of the colon in mice as possible models for chemotherapy.

Ball CR, Double JA.

Br J Cancer. 1975 Feb;31(2):265. No abstract available.

46.
47.

Transplantation of adenocarcinomas of the colon in mice.

Double JA, Ball CR, Cowen PN.

J Natl Cancer Inst. 1975 Jan;54(1):271-5.

PMID:
1113308
48.

Enzyme activated anti-tumour agents. Conjugates of p-hydroxyaniline mustard as substrates for hydrolytic enzymes.

Ball CR, Double JA.

Biochem Pharmacol. 1974 Nov 15;23(22):3173-7. No abstract available.

PMID:
4374212
49.

Proceedings: A comparison of chemical and microbiological methods for estimating alkylating agent concentration.

Toogood SM, Workman P, Ball CR, Garner RC.

Br J Cancer. 1974 Aug;30(2):178. No abstract available.

50.

Enzyme activated alkylating agents.

Ball CR, Double JA, Goodban J.

Br J Cancer. 1973 Jul;28(1):81-2. No abstract available.

Supplemental Content

Support Center